A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

This approach aims to improve treatment for patients with this highly aggressive and treatment-resistant type of breast ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new ...

BofA has initiated coverage of Candel Therapeutics (NASDAQ:CADL) with a buy rating, citing the potential of its immunotherapy drug candidates CAN-2409 and CAN-3110. "While approved therapies may have ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...

Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

Solid tumors that originate in the deep internal organs, such as the pancreas, liver, and ovary, have poor prognoses due to the difficulties of diagnosing ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

This study reveals the key role of microglia, brain’s immune cells, in brain metastases progression and identifies a strategy ...

A team led by the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute has developed ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.